Similar articles

• The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease.

  Kalra PA, Chrysochou C, Green D, Cheung CM, Khavandi K, Sixt S, Rastan A, Zeller T. Kalra PA, et al. Catheter Cardiovasc Interv. 2010 Jan 1;75(1):1-10. doi: 10.1002/ccd.22290. Catheter Cardiovasc Interv. 2010. PMID: 19937777
• Atherosclerotic renal artery stenosis: medical therapy alone or in combination with revascularization?

  Karagiannis A, Tziomalos K, Anagnostis P, Gossios T, Athyros VG. Karagiannis A, et al. Angiology. 2009 Aug-Sep;60(4):397-402. doi: 10.1177/0003319709334262. Epub 2009 Jun 7. Angiology. 2009. PMID: 19505885 No abstract available.
• Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period.

  Mousa AY, Campbell JE, Stone PA, Broce M, Bates MC, AbuRahma AF. Mousa AY, et al. J Vasc Surg. 2012 Feb;55(2):421-7. doi: 10.1016/j.jvs.2011.09.006. Epub 2011 Nov 23. J Vasc Surg. 2012. PMID: 22112553
• The role of percutaneous revascularization for renal artery stenosis.

  Dubel GJ, Murphy TP. Dubel GJ, et al. Vasc Med. 2008;13(2):141-56. doi: 10.1177/1358863x07085408. Vasc Med. 2008. PMID: 18593803 Review.
• Stenting for atherosclerotic renal artery stenosis.

  Carr TM 3rd, Sabri SS, Turba UC, Park AW, Saad WE, Angle JF, Matsumoto AH. Carr TM 3rd, et al. Tech Vasc Interv Radiol. 2010 Jun;13(2):134-45. doi: 10.1053/j.tvir.2010.02.008. Tech Vasc Interv Radiol. 2010. PMID: 20540922 Review.